
A new treatment for asthma attacks is being described as “game-changing” by the London scientists who created it.
The drug, which is called benralizumab, is the first new treatment for asthma attacks and chronic obstructive pulmonary disease (COPD) in 50 years. A trial has shown that using the drug can cut the need for further treatment by 30 per cent.